Patents by Inventor Thomas von Hirschheydt

Thomas von Hirschheydt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060211750
    Abstract: The present invention relates to the compounds of formula I their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, compositions containing such compounds and their manufacture, as well as the use of such compounds in the control or prevention of illnesses such as cancer.
    Type: Application
    Filed: September 14, 2005
    Publication date: September 21, 2006
    Inventors: Walter-Gunar Friebe, Ulrike Reiff, Thomas von Hirschheydt, Edgar Voss
  • Publication number: 20060116407
    Abstract: The present invention relates to the compounds of formula I their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
    Type: Application
    Filed: November 15, 2005
    Publication date: June 1, 2006
    Inventors: Birgit Bossenmaier, Walter-Gunar Friebe, Eike Hoffmann, Thomas von Hirschheydt, Edgar Voss
  • Publication number: 20060069095
    Abstract: Compounds of formula I their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, are disclosed. Also disclosed are methods of preparation of the above-mentioned compounds, pharmaceutical compositions and salts and esters thereof containing them, as well as the use of the above-mentioned compounds in the treatment, control or prevention of illnesses such as cancer.
    Type: Application
    Filed: September 21, 2005
    Publication date: March 30, 2006
    Inventors: Thomas Hofmeister, Ulrike Reiff, Thomas von Hirschheydt, Edgar Voss
  • Patent number: 6946471
    Abstract: This invention is directed to compounds of formula (I), which are valuable therapeutics for the treatment of cancer and cancer related diseases.
    Type: Grant
    Filed: May 18, 2004
    Date of Patent: September 20, 2005
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Michael Brandt, Georg Fertig, Hans-Willi Krell, Thomas von Hirschheydt, Edgar Voss
  • Publication number: 20050113342
    Abstract: Compounds of the general formula (I) are presented which arevaluable therapeutics for the treatment of cancer and cancer related diseases.
    Type: Application
    Filed: October 12, 2004
    Publication date: May 26, 2005
    Inventors: Konrad Honold, Stefan Scheiblich, Thomas von Hirschheydt, Edgar Voss
  • Publication number: 20040214874
    Abstract: 1
    Type: Application
    Filed: May 18, 2004
    Publication date: October 28, 2004
    Inventors: Michael Brandt, George Fertig, Hans-Willi Krell, Thomas von Hirschheydt, Edgar Voss
  • Patent number: 6790852
    Abstract: The invention is directed to compounds of formula (I), which are valuable therapeutics for the treatment of cancer and related diseases.
    Type: Grant
    Filed: April 7, 2003
    Date of Patent: September 14, 2004
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Michael Brandt, Georg Fertig, Hans-Willi Krell, Thomas von Hirschheydt, Edgar Voss
  • Publication number: 20030199691
    Abstract: 1
    Type: Application
    Filed: April 7, 2003
    Publication date: October 23, 2003
    Inventors: Michael Brandt, Georg Fertig, Hans-Willi Krell, Thomas von Hirschheydt, Edgar Voss